![](/img/cover-not-exists.png)
PO10-TU-32 The Rebif new formulation versus Betaseron tolerability study: twelve week comparative phase findings
B. Singer, D. Jeffery, S. Kirzinger, R. Bennett, A. AL-Sabbagh, F. DangondVolume:
285
Year:
2009
Language:
english
DOI:
10.1016/s0022-510x(09)70781-6
File:
PDF, 46 KB
english, 2009